Choosing Route of Consumption
Dr. Sarah Mann, an intensive care doctor, explores the various modes of administration for cannabis medicine and the pros and cons of each.
Archive for month: May, 2020
Totality of the Evidence Suggests Prenatal Cannabis Exposure Does Not Lead to Cognitive Impairments: A Systematic and Critical Review
Groundbreaking research reviewed 40 studies examining the impact of prenatal cannabis use and cognitive function. The authors reported, “The current evidence does not suggest that prenatal cannabis exposure alone is associated with clinically significant cognitive functioning impairments.”
Cannabis in the Time of Coronavirus Disease 2019: The Yin and Yang of the Endocannabinoid System in Immunocompetence
Are phytocannabinoids helpful or harmful for immune competency in the context of the current coronavirus pandemic?
Women, Babies, Kids and Cannabis
Melanie Dreher, PhD, RN, FAAN gives an in depth account of her groundbreaking anthropological research on the use of cannabis medicine in Jamaica. Recorded in 2018 at Sonoma State University.
Physician Roundtable – Cannabis in Pediatrics
A roundtable discussion featuring Society of Cannabis Clinician’s members Dr. Bonni Goldstein, Dr. Dustin Sulak, and Dr. Jeffrey Hergenrather on the applications of cannabis in pediatric care. They share case studies on treating kids and adolescents in their clinical practice with autism, epilepsy, and other conditions.
Cannabis for Hospice & Palliative Care
Explore the applications of cannabis for hospice and palliative care with Valerie Leveroni-Corral. Valerie highlights four case studies and discusses various dosing regimens and protocols that she has used in her work. Valerie is the cofounder of WAMM Phytotherapies, a non-profit organization that has provided cannabis medicine to low income, chronically ill patients for decades.
Legal implications of recommending cannabis
Know your rights as a cannabis recommending physician. Lawyer Michael Levinsohn outlines legal considerations for healthcare providers in regard to cannabis in clinical practice. He explains the nuances of recommending cannabis in California state which can be useful guidelines for elsewhere.
Medical Board of California- Cannabis Recommendations
Kimberly Kirchmeyer of the Medical Board of California discusses the guidelines for recommending cannabis for medicinal purposes. This includes details on patient evaluation, shared decision making, qualifying conditions, treatment agreements, and conflicts of interest.
Intro to the Endocannabinoid System
Dr. Sherry Yafai of the Releaf Institute gives the basics on the endocannabinoid system and cannabinoids. By the end of this lecture, participants will be able to describe the endocannabinoid system and relevant receptors, assess the current clinical evidence for cannabinoids as a therapeutic treatment option, and as well as discussing the need for further education for healthcare providers.
Open Letter to the United Nations: Ensuring Continued Medical Cannabis Access During the COVID-19 Pandemic
The Society of Cannabis Clinicians, along with various organizations, sent a letter to the United Nations urging representatives to ease access to medical cannabis for patients across the world during the COVID-19 pandemic.